Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

For 6 years, a college cross-country skier experiened pain that kept her from school and skiing. Finally, she was diagnosed ...

Since its launch on 2 January, Sebaashray has redefined healthcare accessibility in Diamond Harbour, touching the lives of ...

Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold 6,165 shares of the company's common stock. The shares ...

Cushing syndrome, which is also called Cushing’s syndrome, is a disorder that happens when your body makes too much of the ...

Infants with SMA type 1 born since 2016 experience better functional outcomes and life expectancy with disease-modifying treatments.

A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Sarawak Multimedia Authority (SMA) general manager Datuk Anderson Tiong Ing Heng said that last year, it also strengthened the cybersecurity for the state government's agencies through the ...

It can also trigger anxiety and depression, primarily because you don't know when an episode will occur or how long an episode will last.

Cure SMA is leading an advocacy campaign seeking new research funding to address unmet challenges for people with SMA.